Operator
Good day, and thank you for standing by. Welcome to the Alamar Biosciences Second Quarter 2026 Financial Results Webcast Call. [Operator Instructions] Please be advised that today’s conference is being recorded.
I would now like to hand the conference over to your first speaker today, Carrie Mendivil, Vice President of Investor Relations and Corporate Communications. Please proceed.
Carrie Mendivil
Good afternoon, everyone, and thank you for joining us today to review Alamar Biosciences’ Second Quarter 2026 Financial Results. Joining me on the call are Yuling Luo, our Chief Executive Officer; and Justin McAnear, Chief Financial Officer. Our President, Tod White, will join for Q&A.
Earlier this afternoon, we issued a press release detailing our second quarter financial results, and we posted an accompanying presentation in the Investors section of our website.
Before we begin, I’d like to remind you that statements we make during this call will include forward-looking statements as defined under applicable securities laws. Forward-looking statements are subject to risks and uncertainties, and the company can give no assurance that they will prove to be correct. Additionally, we are not under any obligation to provide further updates on our business trends or our performance during the quarter. To better understand the risks and uncertainties that could cause actual results to differ, we refer you to the periodic reports that Alamar Biosciences files with the Securities and Exchange Commission, including